Stepan Reports Q1 2025 Earnings with Increased Adjusted EBITDA and Net Income
Stepan (SCL) reported Q1 2025 earnings with adjusted EBITDA of $57.5 million, up 12% year over year, driven by volume growth and higher Surfactant margins. Adjusted net income rose 32% to $19.3 million, supported by lower effective tax rates and improved earnings in Surfactant and Specialty Products segments. Volume growth across key product lines was reported, though some segments faced margin pressures.
Topics: cash flow earnings EBITDA financial results net income sales volume growth